热门资讯> 正文

Myriad Genetics announces CFO appointment

2025-08-18 20:43

Ben Wheeler appointed chief financial officer of Myriad Genetics (NASDAQ:MYGN), effective August 16, 2025.
Wheeler has been with the company since 2011, most recently serving as CFO of Operations since 2022.
Outgoing CFO Scott Leffler will move into a consulting role until September 2, 2025.
Source: Press release

More on Myriad Genetics

Myriad: HCT In Oncology Continues To Deliver Increased Volume And Revenue Growth
Myriad Genetics, Inc. 2025 Q2 - Results - Earnings Call Presentation
Myriad Genetics, Inc. (MYGN) Q2 2025 Earnings Call Transcript
Myriad Genetics outlines high single-digit to low double-digit growth target through cancer care continuum focus
Myriad Genetics Non-GAAP EPS of $0.05 beats by $0.06, revenue of $213.1M beats by $10.8M

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。